ACTIVE INGREDIENT: Etoricoxib
STRENGTH, PACK SIZE & GMS CODES:
30 mg Film-coated Tablets x 28 – 36874
60 mg Film-coated Tablets x 28 – 36875
90mg Film-coated Tablets x 28 – 36876
- Etoricoxib is indicated in adults and adolescents 16 years of age and older for the symptomatic relief of osteoarthritis (OA), rheumatoid arthritis (RA), ankylosing spondylitis, and the pain and signs of inflammation associated with acute gouty arthritis.
- Etoricoxib is indicated in adults and adolescents 16 years of age and older for the short-term treatment of moderate pain associated with dental surgery.
- The decision to prescribe a selective COX-2 inhibitor should be based on an assessment of the individual patient’s overall risks.